0001209191-21-011523.txt : 20210217
0001209191-21-011523.hdr.sgml : 20210217
20210217193801
ACCESSION NUMBER: 0001209191-21-011523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210217
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GV 2016, L.P.
CENTRAL INDEX KEY: 0001721789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40030
FILM NUMBER: 21647032
BUSINESS ADDRESS:
STREET 1: 1600 AMPHITHEATRE PARKWAY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-335-5278
MAIL ADDRESS:
STREET 1: 1600 AMPHITHEATRE PARKWAY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GV 2016 GP, L.P.
CENTRAL INDEX KEY: 0001722204
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40030
FILM NUMBER: 21647033
BUSINESS ADDRESS:
STREET 1: 1600 AMPHITHEATRE PARKWAY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-335-5278
MAIL ADDRESS:
STREET 1: 1600 AMPHITHEATRE PARKWAY
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GV 2016 GP, L.L.C.
CENTRAL INDEX KEY: 0001722201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40030
FILM NUMBER: 21647034
BUSINESS ADDRESS:
STREET 1: 1600 AMPHITHEATRE PARKWAY
CITY: MOUNTAIN VIEW
STATE: MA
ZIP: 94043
BUSINESS PHONE: 650-335-5278
MAIL ADDRESS:
STREET 1: 1600 AMPHITHEATRE PARKWAY
CITY: MOUNTAIN VIEW
STATE: MA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Decibel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001656536
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464198709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: 617-370-8701
MAIL ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-17
1
0001656536
Decibel Therapeutics, Inc.
DBTX
0001722201
GV 2016 GP, L.L.C.
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW
CA
94043
0
0
1
0
0001722204
GV 2016 GP, L.P.
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW
CA
94043
0
0
1
0
0001721789
GV 2016, L.P.
1600 AMPHITHEATRE PARKWAY
MOUNTAIN VIEW
CA
94043
0
0
1
0
Common Stock
2021-02-17
4
C
0
321978
A
321978
I
By GV 2016, L.P.
Series A Preferred Stock
2021-02-17
4
C
0
5000000
D
Common Stock
321978
0
I
By GV 2016, L.P.
The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 15.529:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.
The reported securities are held directly by GV 2016, L.P. GV 2016 GP, L.P. (the general partner of GV 2016, L.P.), GV 2016 GP, L.L.C. (the general partner of GV 2016 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2016 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2016 GP, L.P., GV 2016 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
/s/ Winston Macaraeg, Attorney-in-Fact
2021-02-17